Literature DB >> 10965402

Microvessel quantitation in intraductal and early invasive breast carcinomas.

A Santinelli1, M Baccarini, P Colanzi, G Fabris.   

Abstract

OBJECTIVE: To study the angiogenic process in intraductal carcinoma of the breast, with and without a small focus of stromal infiltration, and to compare the microvessel density between the in situ phase and the early infiltration phases of breast cancer. STUDY
DESIGN: Microvessel density (number of microvessels per square millimeter of neoplasia) was quantitatively evaluated on anti-factor VIII-immunostained histologic sections obtained from 10 ductal carcinomas in situ (DCIS) (category A), 22 DCIS with a small focus of stromal infiltration (category B), 10 microinvasive carcinomas (category C), 12 T1a carcinomas (category D) and 20 T1b carcinomas (category E).
RESULTS: The five categories of lesion had different values for microvessel density (P = .0017). Category A had microvessel density lower than category B (P = .0005). Category B had microvessel density higher than categories C, D and E (P = .0028, .0133 and .0033, respectively).
CONCLUSION: Microvessel density seems to be a feature related to each crucial step in the early phases of neoplastic progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965402

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  2 in total

1.  Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.

Authors:  Keiko Oshida; Takeshi Nagashima; Takuya Ueda; Hiroshi Yagata; Naoto Tanabe; Shigeharu Nakano; Takashi Nikaidou; Hiroyuki Funatsu; Hideyuki Hashimoto; Masaru Miyazaki
Journal:  Eur Radiol       Date:  2005-03-24       Impact factor: 5.315

2.  Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.

Authors:  Natsuko Onishi; Meredith Sadinski; Mary C Hughes; Eun Sook Ko; Peter Gibbs; Katherine M Gallagher; Maggie M Fung; Theodore J Hunt; Danny F Martinez; Amita Shukla-Dave; Elizabeth A Morris; Elizabeth J Sutton
Journal:  Breast Cancer Res       Date:  2020-05-28       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.